203 related articles for article (PubMed ID: 20958264)
21. Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells.
Gravina GL; Festuccia C; Angelucci A; Poletti A; Capuano D; Vicentini C; Motta M; Bologna M
Int J Oncol; 2004 Jul; 25(1):97-104. PubMed ID: 15201994
[TBL] [Abstract][Full Text] [Related]
22. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
Novellasdemunt L; Obach M; Millán-Ariño L; Manzano A; Ventura F; Rosa JL; Jordan A; Navarro-Sabate A; Bartrons R
Biochem J; 2012 Mar; 442(2):345-56. PubMed ID: 22115192
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
24. Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia.
Ellis R; Katerelos M; Choy SW; Cook N; Lee M; Paizis K; Pell G; Walker S; Power DA; Mount PF
J Transl Med; 2019 Feb; 17(1):60. PubMed ID: 30819197
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
26. A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells.
Arden C; Hampson LJ; Huang GC; Shaw JA; Aldibbiat A; Holliman G; Manas D; Khan S; Lange AJ; Agius L
Biochem J; 2008 Apr; 411(1):41-51. PubMed ID: 18039179
[TBL] [Abstract][Full Text] [Related]
27. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells.
Bai G; Kasper S; Matusik RJ; Rennie PS; Moshier JA; Krongrad A
J Androl; 1998; 19(2):127-35. PubMed ID: 9570735
[TBL] [Abstract][Full Text] [Related]
28. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
29. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.
Cheng H; Snoek R; Ghaidi F; Cox ME; Rennie PS
Cancer Res; 2006 Nov; 66(21):10613-20. PubMed ID: 17079486
[TBL] [Abstract][Full Text] [Related]
30. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
[TBL] [Abstract][Full Text] [Related]
31. PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli.
Novellasdemunt L; Bultot L; Manzano A; Ventura F; Rosa JL; Vertommen D; Rider MH; Navarro-Sabate À; Bartrons R
Biochem J; 2013 Jun; 452(3):531-43. PubMed ID: 23548149
[TBL] [Abstract][Full Text] [Related]
32. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
33. Triptolide restrains the growth, invasion, stemness, and glycolysis of non-small cell lung cancer cells by PFKFB2-mediated PI3K/AKT pathway.
Ren J; Zhao S; Lai J
Chem Biol Drug Des; 2024 Jan; 103(1):e14450. PubMed ID: 38230789
[TBL] [Abstract][Full Text] [Related]
34. Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
Sun RF; Zhao CY; Chen S; Yu W; Zhou MM; Gao CR
Dig Dis Sci; 2021 Mar; 66(3):802-813. PubMed ID: 32274668
[TBL] [Abstract][Full Text] [Related]
35. Analysis of androgen-induced increase in lipid accumulation in prostate cancer cells.
Sikkeland J; Lindstad T; Saatcioglu F
Methods Mol Biol; 2011; 776():371-82. PubMed ID: 21796538
[TBL] [Abstract][Full Text] [Related]
36. UCP2 overexpression enhanced glycolysis via activation of PFKFB2 during skin cell transformation.
Sreedhar A; Petruska P; Miriyala S; Panchatcharam M; Zhao Y
Oncotarget; 2017 Nov; 8(56):95504-95515. PubMed ID: 29221144
[TBL] [Abstract][Full Text] [Related]
37. Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex.
Smith WE; Langer S; Wu C; Baltrusch S; Okar DA
Mol Endocrinol; 2007 Jun; 21(6):1478-87. PubMed ID: 17374851
[TBL] [Abstract][Full Text] [Related]
38. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
[TBL] [Abstract][Full Text] [Related]
39. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
40. 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase.
Pozuelo Rubio M; Peggie M; Wong BH; Morrice N; MacKintosh C
EMBO J; 2003 Jul; 22(14):3514-23. PubMed ID: 12853467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
